Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas

作者: Elizabeth W. Newcomb , Michelle Alonso , Tammy Sung , Douglas C. Miller

DOI: 10.1016/S0046-8177(00)80207-5

关键词:

摘要: The INK4a-ARF locus encodes 2 separate proteins through differential splicing of alternative first exons to produce p16 INK4a (exon 1α) and p14 ARF 1β) products in human cells. protein inhibits the cyclin D-dependent kinases (CDK) that control phosphorylation Rb cell proliferation. gene product can complex with sequester MDM2 within nucleus, thus modulating activity p53 protein. Loss expression would disrupt retinoblastoma (Rb)/p16 /cyclin kinase (CDK4) pathway, whereas loss inactivate both p53/MDM2/p14ARF pathways MDM2, which either or p53. on 9p21 has been documented a wide range tumors, including one third glioblastomas. However, tumors showing homozygous exon gene, 1β not established. In this study, we have assessed deletion 29 pediatric 107 adult high-grade astrocytomas 9 glioma lines, using multiplex PCR analysis for 1β. We found deletions 1α 3 (10%) cases (2 grade III, 1 IV), 25 (23%) (6 III 19 8 (89%) lines. Therefore, may contribute highly malignant behavior treatment resistance these elimination multiple checkpoint cycle proteins.

参考文章(40)
B. Tycko, M. Sisti, Luwa Yuan, T. Moulton, Ghassan Samara, J. Bruce, Raj Desai, Wai-Yee Chung, MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. American Journal of Pathology. ,vol. 146, pp. 613- 619 ,(1995)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
Abhaya Paladugu, Olufunmilayo I. Olopade, Andrew J. Brenner, Martin H. Dreyling, Hui Wang, C. Marcelo Aldaz, Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer Clinical Cancer Research. ,vol. 2, pp. 1993- 1998 ,(1996)
Andreas von Deimling, Jimmy T. Efird, John W. Henson, David N. Louis, Yasuhiro Ono, Keisuke Ueki, CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Research. ,vol. 56, pp. 150- 153 ,(1996)
Jason D. Weber, Laura J. Taylor, Martine F. Roussel, Charles J. Sherr, Dafna Bar-Sagi, Nucleolar Arf sequesters Mdm2 and activates p53 Nature Cell Biology. ,vol. 1, pp. 20- 26 ,(1999) , 10.1038/8991
S Gazzeri, E Brambilla, C Brambilla, L Chaussade, C J Larsen, V Della Valle, The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer. Cancer Research. ,vol. 58, pp. 3926- 3931 ,(1998)
Sean V. Tavtigian, Harold Katcher, Priya Dayananth, Steven Stone, Ping Jiang, David Parry, Alexander Kamb, Gordon Peters, Complex Structure and Regulation of the P16 (MTS1) Locus Cancer Research. ,vol. 55, pp. 2988- 2994 ,(1995)
R Godbout, J He, MJ Allalunis-Turner, rd Rs Day, VP Collins, JR Allen, CD James, CDK4 Amplification Is an Alternative Mechanism to p16 Gene Homozygous Deletion in Glioma Cell Lines Cancer Research. ,vol. 54, pp. 5804- 5807 ,(1994)
M. Nordenskjold, E. Carlbom, V. P. Collins, W. K. Cavenee, C. D. James, J. He, J. He, Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Research. ,vol. 51, pp. 1684- 1688 ,(1991)